Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

  • Details

ClinicalTrials.gov ID: NCT03906071
Diagnosis Type: NA
USOR Number: 19018

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lymphomas

Clinical Trial at: Minnesota Oncology - Minneapolis

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial Carcinoma (LEAP-001)(MK-7902-001-00)

  • Details

ClinicalTrials.gov ID: NCT03884101
Diagnosis Type: NA
USOR Number: 18143

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Breast Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

MammaPrint, BluePrint, and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry (FLEX Registry)

  • Details

ClinicalTrials.gov ID: NCT03053193
Diagnosis Type: NA
USOR Number: 17079

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

BO39633 (IMbrella A), An open-Label, Multicenter Extension and Long-Term Observational Study in Patients Previously Enrolled in A Genentech- and/or F.Hoffman-La Roche Ltd. sponsored Atezolizumab Study

  • Details

ClinicalTrials.gov ID: NCT03148418
Diagnosis Type: NSCLC
USOR Number: 17087

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20) (SPI-POZ-202)

  • Details

ClinicalTrials.gov ID: NCT03318939
Diagnosis Type: NSCLC
USOR Number: 17143

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

A Parallel Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer (MRTX-500)

  • Details

ClinicalTrials.gov ID: NCT02954991
Diagnosis Type: NSCLC
USOR Number: 17039

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, Minnesota 55404
557.83 mi. away
P: (612) 884-6300

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase III, Randomized, Double-Blind, Placebo-controlled study of Atezolizumab plus Carboplatin and Etoposide with or without Tiragolumab (Anti-Tigit Antibody) in patients with untreated extensive-stage small cell lung cancer (GO41767)

  • Details

ClinicalTrials.gov ID: NCT04256421
Diagnosis Type: NA
USOR Number: 19193

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer (SGN22E-002)

  • Details

ClinicalTrials.gov ID: NCT03288545
Diagnosis Type: NA
USOR Number: 20172

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A study of enfortumab vedotin (ASG-22CE) as monotherapy or in combination with other anticancer therapies for the treatment of urothelial cancer (SGN22E-002)

  • Details

ClinicalTrials.gov ID: NCT03288545
Diagnosis Type: NA
USOR Number: 20172

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer (CA017078)

  • Details

ClinicalTrials.gov ID: NCT03661320
Diagnosis Type: NA
USOR Number: 18095

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase 1b-2 Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer (PCR2002 Quest) (64091742PCR2002)

  • Details

ClinicalTrials.gov ID: NCT03431350
Diagnosis Type: NA
USOR Number: 19146

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase III, Double-blind, Placebo-controlled, Multi-center International Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients with Resectable Stages II and III Non-small Cell Lung Cancer (AEGEAN) (D9106C00001)

  • Details

ClinicalTrials.gov ID: NCT03800134
Diagnosis Type: NA
USOR Number: 19211

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced or Metastatic Biliary Tract Cancer (NuTide:121)

  • Details

ClinicalTrials.gov ID: NCT04163900
Diagnosis Type: NA
USOR Number: 19120

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase 2 Trial of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men with Metastatic Castration-Resistant Prostate Cancer (CA209-650)

  • Details

ClinicalTrials.gov ID: NCT02985957
Diagnosis Type: NA
USOR Number: 19135

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Lung Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

20190009: A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects with Mutated KRAS p.G12C

  • Details

ClinicalTrials.gov ID: NCT04303780
Diagnosis Type: NA
USOR Number: 19143

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, Minnesota 55125
558.75 mi. away
P: (651) 735-7414

More Details View Practice Page

Pages